Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody

Citations Over TimeTop 1% of 2022 papers

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has become the dominant infective strain. We report the structures of the Omicron spike trimer on its own and in complex with angiotensin-converting enzyme 2 (ACE2) or an anti-Omicron antibody. Most Omicron mutations are located on the surface of the spike protein and change binding epitopes to many current antibodies. In the ACE2-binding site, compensating mutations strengthen receptor binding domain (RBD) binding to ACE2. Both the RBD and the apo form of the Omicron spike trimer are thermodynamically unstable. An unusual RBD-RBD interaction in the ACE2-spike complex supports the open conformation and further reinforces ACE2 binding to the spike trimer. A broad-spectrum therapeutic antibody, JMB2002, which has completed a phase 1 clinical trial, maintains neutralizing activity against Omicron. JMB2002 binds to RBD differently from other characterized antibodies and inhibits ACE2 binding.

Related Papers

• → Hydrophobic cavity in C-terminus is essential for hTNF-α trimer conformation(2012)13 cited
• → ESR detection of non-equivalent scandium trimer(1994)15 cited
• → Results and discussion(2015)3 cited
• → 2,3,4,5‐Tetrahydropyridine Trimer(2003)3 cited
• → Influence of trimer water cluster in liquid materials on conduction phenomena by using nano-second pulse(2002)